Exact Mass: 389.10116600000003
Exact Mass Matches: 389.10116600000003
Found 262 metabolites which its exact mass value is equals to given mass value 389.10116600000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Acetyl adenylate
Acetyl adenylate is an intermediate in acetyl-CoA synthesis. It is converted from acetate via the enzyme acetyl-CoA synthetase. It is involved in the non-enzymatic acetylation of histones in chromatin (PMID:8619849). In microbes acetyl adenylate also plays a role in the direction of flagellar rotation (PMID:2901103) [HMDB] Acetyl adenylate is an intermediate in acetyl-CoA synthesis. It is converted from acetate via the enzyme acetyl-CoA synthetase. It is involved in the non-enzymatic acetylation of histones in chromatin (PMID:8619849). In microbes acetyl adenylate also plays a role in the direction of flagellar rotation (PMID:2901103).
N-Acetylneuraminate 9-phosphate
C11H20NO12P (389.0723090000001)
N-Acetylneuraminate 9-phosphate is an intermediate in Aminosugars metabolism. N-Acetylneuraminate 9-phosphate is the 4th to last step in the synthesis of colominate and is converted from N-Acetyl-D-mannosamine-6-phosphate via the enzyme N-Acylneuraminate-9-phosphate synthase (EC 2.5.1.57). It is then converted to N-Acetylneuraminate via the enzyme N-acylneuraminate-9-phosphatase(EC 3.1.3.29). [HMDB] N-Acetylneuraminate 9-phosphate is an intermediate in Aminosugars metabolism. N-Acetylneuraminate 9-phosphate is the 4th to last step in the synthesis of colominate and is converted from N-Acetyl-D-mannosamine-6-phosphate via the enzyme N-Acylneuraminate-9-phosphate synthase (EC 2.5.1.57). It is then converted to N-Acetylneuraminate via the enzyme N-acylneuraminate-9-phosphatase(EC 3.1.3.29).
Cefprozil
C18H19N3O5S (389.10453640000003)
Cefprozil is only found in individuals that have used or taken this drug. It is a cephalosporin antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections.Cefprozil, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefprozil interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Hetacillin
C19H23N3O4S (389.14091980000006)
Hetacillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name penicillin can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Hetacillin has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Hetacillin results from the inhibition of cell wall synthesis and is mediated through Hetacillin binding to penicillin binding proteins (PBPs). J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D01074
xi-8-Acetonyldihydrosanguinarine
C23H19NO5 (389.12631640000006)
(+/-)-6-Acetonyldihydrosanguinarine is a benzophenanthridine alkaloid. (+/-)-6-Acetonyldihydrosanguinarine is a natural product found in Chelidonium majus and Apis cerana with data available. xi-8-Acetonyldihydrosanguinarine is an alkaloid from Papaver somniferum (opium poppy). Alkaloid from Papaver somniferum (opium poppy)
2-Methylbutyl glucosinolate
Tadalafil
C22H19N3O4 (389.13754940000007)
Tadalafil is an orally adminstered drug used to treat male erectile dysfunction (impotence). It is marketed worldwide under the brand name Cialis. It is a phosphodiesterase 5 (PDE5) inhibitor. Tadalafils distinguishing pharmacologic feature is its longer half-life (17.5 hours) compared with Viagra and Levitra (4-5 hours). This longer half-life results in a longer duration of action and is, in part, responsible for the Cialis nickname of the weekend pill. This longer half-life also is the basis of current investigation for tadalafils use in pulmonary arterial hypertension as a once-daily therapy. [Wikipedia] G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
N-Acetylneuraminic acid 9-phosphate
C11H20NO12P (389.0723090000001)
N-Acetylneuraminic acid 9-phosphate is an intermediate in the synthesis of Acetylneuraminic acid, a process occurring in the cytosolic fraction by the human enzyme N-Acetylneuraminic acid 9-phosphate (Neu5Ac 9-P) synthase, that catalyzes the synthesis of N-Acetylneuraminic acid 9-phosphate, in a reaction by the mechanism of aldol condensation of phosphoenolpyruvate (PEP) with sugar substrates, ManNAc-6-P (N-acetylmannosamine 6-phosphate) or Man-6-P (mannose 6-phosphate). N-Acetylneuraminic acid 9-phosphate is converted to N-Acetylneuraminic acid by the enzyme N-acetylneuraminate-9-phosphate phosphatase. (PMID: 16503877, 6093772) [HMDB] N-Acetylneuraminic acid 9-phosphate is an intermediate in the synthesis of Acetylneuraminic acid, a process occurring in the cytosolic fraction by the human enzyme N-Acetylneuraminic acid 9-phosphate (Neu5Ac 9-P) synthase, that catalyzes the synthesis of N-Acetylneuraminic acid 9-phosphate, in a reaction by the mechanism of aldol condensation of phosphoenolpyruvate (PEP) with sugar substrates, ManNAc-6-P (N-acetylmannosamine 6-phosphate) or Man-6-P (mannose 6-phosphate). N-Acetylneuraminic acid 9-phosphate is converted to N-Acetylneuraminic acid by the enzyme N-acetylneuraminate-9-phosphate phosphatase. (PMID: 16503877, 6093772).
3-Methylbutyl glucosinolate
3-Methylbutyl glucosinolate is found in brassicas. 3-Methylbutyl glucosinolate is present in horseradish (Armoracia lapathifolia). Present in horseradish (Armoracia lapathifolia). 3-Methylbutyl glucosinolate is found in horseradish and brassicas.
Pentyl glucosinolate
Present in radish (Raphanus sativus) and in kohlrabi aroma. Pentyl glucosinolate is found in horseradish, brassicas, and radish. Pentyl glucosinolate is found in brassicas. Pentyl glucosinolate is present in radish (Raphanus sativus) and in kohlrabi aroma.
Gemifloxacin
C18H20FN5O4 (389.14992520000004)
Gemifloxacin is an oral broad-spectrum quinolone antibacterial agent used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia. Gemifloxacin acts by inhibiting DNA synthesis through the inhibition of both DNA gyrase and topoisomerase IV, which are essential for bacterial growth. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
C19H14F3N3O3 (389.09872100000007)
2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranosyl isothiocyanate
C15H19NO9S (389.07804840000006)
1-(3-(Naphth-2-ylmethoxy)phenyl)-1-(thiazol-2-yl)propyl methyl ether
Indibulin
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
monophospho-n-acetylneuraminic acid
C11H20NO12P (389.0723090000001)
Prochlorperazine Sulfoxide
C20H24ClN3OS (389.13285240000005)
Taisho
C17H19N5O4S (389.11576940000003)
Brisoral
C18H19N3O5S (389.10453640000003)
7-[(3R)-3-(Aminomethyl)-4-methoxyiminopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid
C18H20FN5O4 (389.14992520000004)
(2S)-2-Amino-3-[4-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]oxy-3-nitrophenyl]propanoic acid
1-Thio-beta-D-glucopyranoside 1-[4-methyl-N-(sulfooxy)pentanimidate]
Azoxystrobin acid
C21H15N3O5 (389.10116600000003)
An aryloxypyrimidine having a 4,6-diphenoxypyrimidine skeleton in which one of the phenyl rings is cyano-substituted at C-2 and the other carries a 1-carboxy-2-methoxyethenyl substituent, also at C-2. It is a metabolite of the fungicidal agrochemical azoxystrobin. CONFIDENCE standard compound; INTERNAL_ID 2031
5-Chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7-methyl-6,8-dioxo-2,6,7,8-tetrahydro-7-isoquinolinyl acetate
C21H24ClNO4 (389.13937740000006)
5-(4-methoxyphenyl)-N-[(5-methyl-2-phenyl-4-triazolyl)methyl]-4-oxazolecarboxamide
C21H19N5O3 (389.1487824000001)
2,3,10-trimethoxy-14-methyl-5-oxo-5,13-dihydro-indolo[2,3:3,4]pyrido[2,1-b]quinazolinium betaine|Euxylophorin-D|Euxylophorine D
C22H19N3O4 (389.13754940000007)
beta-d-glucosamine pentaacetate
CAY10566
CAY10566 is a potent, orally bioavailable and selective stearoyl-CoA desaturase1 (SCD1) inhibitor with IC50s of 4.5 and 26 nM in mouse and human enzymatic assays, respectively. CAY10566 also shows excellent cellular activity in blocking the conversion of saturated long-chain fatty acid-CoAs (LCFA-CoAs) to monounsaturated LCFA-CoAs in HepG2 cells (IC50=7.9 nM or 6.8 nM)[1][2].
Natural Yellow 18
C20H20ClNO5 (389.1029940000001)
Berberine chloride hydrate (Natural Yellow 18 chloride hydrate) is an alkaloid that acts as an antibiotic. Berberine chloride hydrate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1]. Berberine chloride hydrate (Natural Yellow 18 chloride hydrate) is an alkaloid that acts as an antibiotic. Berberine chloride hydrate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1].
Azoxystrobin (free acid)
C21H15N3O5 (389.10116600000003)
CONFIDENCE standard compound; EAWAG_UCHEM_ID 2734
C21H24ClNO4_5-Chloro-3-[(1E,3E)-3,5-dimethyl-1,3-heptadien-1-yl]-7-methyl-6,8-dioxo-2,6,7,8-tetrahydro-7-isoquinolinyl acetate
C21H24ClNO4 (389.13937740000006)
[5-chloro-3-[(1E,3E)-3,5-dimethylhepta-1,3-dienyl]-7-methyl-6,8-dioxo-2H-isoquinolin-7-yl] acetate
C21H24ClNO4 (389.13937740000006)
Cialis
C22H19N3O4 (389.13754940000007)
A pyrazinopyridoindole that is 2,3,6,7,12,12a-hexahydropyrazino[1,2:1,6]pyrido[3,4-b]indole-1,4-dione substituted at position 2 by a methyl group and at position 6 by a 1,3-benzodioxol-5-yl group (the 6R,12aR-diastereomer). A phosphodiesterase V inhibitor inhibitor, currently marketed in pill form for treating erectile dysfunction under the name Cialis; and under the name Adcirca for the treatment of pulmonary arterial hypertension. G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Cys Gly Asn Pro
C14H23N5O6S (389.13689780000004)
Cys Gly Pro Asn
C14H23N5O6S (389.13689780000004)
Cys Asn Gly Pro
C14H23N5O6S (389.13689780000004)
Cys Asn Pro Gly
C14H23N5O6S (389.13689780000004)
Cys Pro Gly Asn
C14H23N5O6S (389.13689780000004)
Cys Pro Asn Gly
C14H23N5O6S (389.13689780000004)
Gly Cys Asn Pro
C14H23N5O6S (389.13689780000004)
Gly Cys Pro Asn
C14H23N5O6S (389.13689780000004)
Gly Asn Cys Pro
C14H23N5O6S (389.13689780000004)
Gly Asn Pro Cys
C14H23N5O6S (389.13689780000004)
Gly Pro Cys Asn
C14H23N5O6S (389.13689780000004)
Gly Pro Asn Cys
C14H23N5O6S (389.13689780000004)
Asn Cys Gly Pro
C14H23N5O6S (389.13689780000004)
Asn Cys Pro Gly
C14H23N5O6S (389.13689780000004)
Asn Gly Cys Pro
C14H23N5O6S (389.13689780000004)
Asn Gly Pro Cys
C14H23N5O6S (389.13689780000004)
Asn Pro Cys Gly
C14H23N5O6S (389.13689780000004)
Asn Pro Gly Cys
C14H23N5O6S (389.13689780000004)
Pro Cys Gly Asn
C14H23N5O6S (389.13689780000004)
Pro Cys Asn Gly
C14H23N5O6S (389.13689780000004)
Pro Gly Cys Asn
C14H23N5O6S (389.13689780000004)
Pro Gly Asn Cys
C14H23N5O6S (389.13689780000004)
Pro Asn Cys Gly
C14H23N5O6S (389.13689780000004)
Pro Asn Gly Cys
C14H23N5O6S (389.13689780000004)
Gemifloxacin
C18H20FN5O4 (389.14992520000004)
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones D004791 - Enzyme Inhibitors A 1,4-dihydro-1,8-naphthyridine with a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a substituted pyrrolin-1-yl group at the 7-position. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic
CAY10607
C19H20ClN3O4 (389.1142270000001)
Epoxy Fluor 7
C23H19NO5 (389.12631640000006)
3-Methylbutyl glucosinolate
Pentyl glucosinolate
3-[2-oxo-3-(4-phenoxyphenoxy)pyrrolidin-1-yl]benzoic acid
C23H19NO5 (389.12631640000006)
a-D-Glucopyranose,2-(acetylamino)-2-deoxy-, 1,3,4,6-tetraacetate
(S)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-2-(4-HYDROXYPHENYL)ACETIC ACID
C23H19NO5 (389.12631640000006)
2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-2-(4-HYDROXYPHENYL)ACETIC ACID
C23H19NO5 (389.12631640000006)
(R)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-2-(4-HYDROXYPHENYL)ACETIC ACID
C23H19NO5 (389.12631640000006)
[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridin-6-ol,5b,6,7,12b,13,14-hexahydro-13-methyl-, hydrochloride (1:1), (5bR,6S,12bS)-
C20H20ClNO5 (389.1029940000001)
METHYL-3-NITRO-4-(3,5-DICARBOXYMETHYL-PHENOXY)-BENZOATE
tert-butyl 4-(5-iodopyridin-2-yl)piperazine-1-carboxylate
Ostarine D4
C19H14F3N3O3 (389.09872100000007)
Ostarine
C19H14F3N3O3 (389.09872100000007)
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen
N-[2-[(2-chloro-4-nitrophenyl)azo]-5-(diethylamino)phenyl]acetamide
C18H20ClN5O3 (389.1254600000001)
(2,3,4,5,6-pentafluorophenyl) 6-(oxan-4-yloxy)pyridine-3-carboxylate
C17H12F5NO4 (389.06864520000005)
(6E)-2,4-ditert-butyl-6-[(4-chloro-2-nitrophenyl)hydrazinylidene]cyclohexa-2,4-dien-1-one
2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-alpha-D-glucopyranose
(1R,2S)-FMOC-2-AMINO-1-CYCLOPENTANECARBOXYLIC ACID
C23H19NO5 (389.12631640000006)
Fmoc-2-amino-5-methoxybenzoic acid
C23H19NO5 (389.12631640000006)
4-[2-(4-tert-Butoxycarbonylpiperazin-1-yl)thiazol-4-yl]benzoic acid
C19H23N3O4S (389.14091980000006)
benzyl 3-(3-chlorophenyl)-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate
C21H24ClNO4 (389.13937740000006)
3-N-BOC-AMINO-3-(4-CHLOROPHENYL)PROPIONIC ACID BENZYL ESTER
C21H24ClNO4 (389.13937740000006)
2-CHLORO-5-(6-METHOXY-7-(2-METHOXYETHOXY)QUINAZOLIN-4-YLAMINO)CYCLOHEXA-2,5-DIENE-1,4-DIONE
C18H16ClN3O5 (389.07784360000005)
7-(2H-naphtho[1,2-d]triazol-2-yl)-3-phenyl-2-benzopyrone
(3R)-3-amino-4-(2,5-difluorophenyl)-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one
(3R)-3-Amino-4-(2,4-difluorophenyl)-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-1-butanone
Vanadium,oxobis(1-phenyl-1,3-butanedionato-kO1,kO3)-
((Methylimino)diethylene)bis(ethyldimethylammonium bromide)
Indeglitazar
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist Indeglitazar (PPM 204) is an orally available PPAR pan-agonist for all three PPARα, PPARδ and PPARγ[1].
Metoclopramide dihydrochloride monohydrate
C14H26Cl3N3O3 (389.10396560000004)
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents
1-(3-(Naphth-2-ylmethoxy)phenyl)-1-(thiazol-2-yl)propyl methyl ether
Acetic acid [4-[[3-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]anilino]-oxomethyl]phenyl] ester
C21H15N3O5 (389.10116600000003)
N-(2-chlorobenzyl)-1-(2,5-dimethylphenyl)benzimidazole-5-carboxamide
C23H20ClN3O (389.12948200000005)
N-[2-(3,4-Dihydro-3-oxo-2-quinoxalinyl)-4-(1-methylethyl)phenyl]-2-thiophenecarboxamide
C22H19N3O2S (389.11979140000005)
(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
C19H14F3N3O3 (389.09872100000007)
N-[5-amino-4-(1,3-benzothiazol-2-yl)-3-oxo-2H-pyrrol-1-yl]-1H-indole-3-carboxamide
4-Chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol
C19H20ClN3O4 (389.1142270000001)
Adenosine-5-monophosphate-propyl ester
C13H20N5O7P (389.11003000000005)
6-{4-[4-(4-Chlorophenyl)piperidin-4-Yl]phenyl}-9h-Purine
C22H20ClN5 (389.14071500000006)
2-[(1r)-1-Carboxy-2-Naphthalen-1-Ylethyl]-1,3-Dioxo-2,3-Dihydro-1h-Isoindole-5-Carboxylic Acid
C22H15NO6 (389.08993300000003)
N-[(2-Amino-6-methylpyrimidin-4-YL)methyl]-3-{[(E)-(2-oxodihydrofuran-3(2H)-ylidene)methyl]amino}benzenesulfonamide
C17H19N5O4S (389.11576940000003)
N-[4-(2-Chlorophenyl)-1,3-Dioxo-1,2,3,6-Tetrahydropyrrolo[3,4-C]carbazol-9-Yl]formamide
C21H12ClN3O3 (389.0567152000001)
(6s)-1-Chloro-3-[(4-Fluorobenzyl)oxy]-6-(Pyrrolidin-1-Ylcarbonyl)pyrrolo[1,2-A]pyrazin-4(6h)-One
(2S)-2-(3-carbamimidamidophenyl)-3-[hydroxy(3-phenylpropyl)phosphoryl]propanoic acid
C19H24N3O4P (389.15043540000005)
(2e,3e)-4-(2-Aminoethoxy)-2-[({3-Hydroxy-2-Methyl-5-[(Phosphonooxy)methyl]pyridin-4-Yl}methyl)imino]but-3-Enoic Acid
C14H20N3O8P (389.09879700000005)
Hetacillin
C19H23N3O4S (389.14091980000006)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D01074
Indibulin
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
Acetic acid [1-[(4,8-dimethoxy-7-furo[2,3-b]quinolinyl)oxy]-3-hydroxy-3-methylbutan-2-yl] ester
(2S,4S,5R,6R)-5-acetamido-6-[(1R,2R)-1,2-dihydroxy-3-phosphonooxypropyl]-2,4-dihydroxyoxane-2-carboxylic acid
C11H20NO12P (389.0723090000001)
7-[[2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
C18H19N3O5S (389.10453640000003)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
(2S)-2-Amino-3-[4-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]oxy-3-nitrophenyl]propanoic acid
(4E)-4-[2-(2-carboxy-5,6-dihydroxy-2,3-dihydroindol-1-ium-1-ylidene)ethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylic acid
Brisoral
C18H19N3O5S (389.10453640000003)
A semisynthetic, second-generation cephalosporin, with prop-1-enyl and (R)-2-amino-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used to treat bronchitis as well as ear, skin and other bacterial infections. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
6-(1,3-benzodioxol-5-yl)-N-ethyl-N-(thiophen-2-ylmethyl)-4-quinazolinamine
C22H19N3O2S (389.11979140000005)
2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-(3-methoxyphenyl)benzamide
C22H16FN3O3 (389.11756379999997)
N-bis(2-fluorophenoxy)phosphoryl-3,4-dimethylaniline
2-chloro-N-[3-[(6-methoxy-1,3-benzothiazol-2-yl)amino]-3-oxopropyl]benzamide
C18H16ClN3O3S (389.0600856000001)
2-(4-((2-Hydroxy-benzoyl)-hydrazonomethyl)-phenoxy)-N-phenyl-acetamide
C22H19N3O4 (389.13754940000007)
4-(2-fluorophenyl)-5-(furan-2-ylmethyl)-3-(2-hydroxyphenyl)-4,5-dihydropyrrolo[3,4-c]pyrazol-6(2H)-one
C22H16FN3O3 (389.11756379999997)
2-[acetyl(2-furanylmethyl)amino]-N-(4-chlorophenyl)-5-methyl-4-thiazolecarboxamide
C18H16ClN3O3S (389.0600856000001)
7-Anilino-1-(4-methylphenyl)-5-oxo-[1,2,4]triazolo[4,3-a]pyrimidine-3-carboxylic acid ethyl ester
C21H19N5O3 (389.1487824000001)
N-(1,3-benzodioxol-5-ylmethyl)-6-(2-chlorophenyl)-4-quinazolinamine
6-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-[(4-methyl-2-thiophenyl)methyl]-4-quinazolinamine
C22H19N3O2S (389.11979140000005)
maritinamine Trifluoroacetic acid
C18H22F3NO5 (389.14499980000005)
A natural product found in Crinum asiaticum var. sinicum.
4-(4-methoxyphenyl)sulfonyl-N-(phenylmethyl)-1-piperazinecarboxamide
C19H23N3O4S (389.14091980000006)
2-[(1,5-diphenyl-2-imidazolyl)thio]-N-(2-furanylmethyl)acetamide
C22H19N3O2S (389.11979140000005)
2-(3,5-dimethylphenoxy)-N-[3-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide
C22H19N3O4 (389.13754940000007)
[3,5-Bis[(phenylmethyl)amino]-1,2,4-triazol-1-yl]-thiophen-2-ylmethanone
C21H19N5OS (389.13102440000006)
2-(4-chlorophenyl)-N-[[2-(4-morpholinyl)anilino]-sulfanylidenemethyl]acetamide
C19H20ClN3O2S (389.09646900000007)
1-(3,4-Dimethoxyphenyl)-3-[[2-(4-ethoxyphenyl)-1-oxoethyl]amino]thiourea
C19H23N3O4S (389.14091980000006)
3-methyl-4-oxo-1-phthalazinecarboxylic acid [2-(7-ethyl-1H-indol-3-yl)-2-oxoethyl] ester
C22H19N3O4 (389.13754940000007)
ethyl 4-[2-(2,6-dimethoxybenzoyl)oxyacetyl]-2,5-dimethyl-1H-pyrrole-3-carboxylate
N-[2-(4-chlorophenyl)ethyl]-2-[3-[(2-fluorophenyl)methyl]-2-oxo-1-imidazolidinyl]acetamide
N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]-2-phenoxybutanamide
C22H19N3O4 (389.13754940000007)
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide dihydrochloride monohydrate
C14H26Cl3N3O3 (389.10396560000004)
2-Chloro-N-[(E)-(5-morpholin-4-ylthiophen-2-yl)methylideneamino]-5-(trifluoromethyl)aniline
Ethyl 4-{[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino}benzoate
C17H12F5NO4 (389.06864520000005)
1-S-[(1Z)-N-(sulfooxy)hexanimidoyl]-1-thio-beta-D-glucopyranose
1-S-[(1Z)-3-methyl-N-(sulfooxy)pentanimidoyl]-1-thio-beta-D-glucopyranose
2-[4-(3,4-Dichlorophenyl)piperazin-1-yl]-1-(imidazo[1,2-a]pyrimidin-3-yl)ethanone
C18H17Cl2N5O (389.08100920000004)
(5Z)-5-[(4-methylphenyl)methylidene]-3-[3-(4-methylpiperazin-1-yl)-3-oxopropyl]-2-sulfanylidene-1,3-thiazolidin-4-one
Sclerotioramine, >=95\\% (LC/MS-UV)
C21H24ClNO4 (389.13937740000006)
N-Acetylneuraminic acid 9-phosphate
C11H20NO12P (389.0723090000001)
2-methylbutylglucosinolic acid
An alkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 3-methyl-N-(sulfooxy)pentanimidoyl group at the anomeric sulfur.
pentylglucosinolic acid
An alkylglucosinolic acid that has pentyl as the alkyl group.
(Rac)-Razpipadon
C19H17F2N3O4 (389.11870660000005)
PW0464, a nanomolar potent complete G protein biased ligand, is a noncatechol D1R agonist, with an EC50 of 5.8 nM (Gs-cAMP)[1].
Epsilon-(gamma-glutamyl)-lysine (TFA)
C13H22F3N3O7 (389.14097780000003)
Epsilon-(gamma-glutamyl)-lysine (H-Glu(H-Lys-OH)-OH) TFA is an N(6)-acyl-L-lysine derivative. The enzyme tissue transglutaminase (tTg) helps the formation of epsilon-(gamma-glutamyl)lysine bonds between ECM components in some disease, such as non-diabetic kidney, glaucoma filtration[1].
VU6000918
C18H17F2N5OS (389.11218160000004)
VU6000918 is a muscarinic acetylcholine (M4) positive allosteric modulator, with an EC50 of 19 nM for hM4[1].
(1r)-5,6,7-trimethyl-4-methylidene-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate
5,6,7-trimethyl-4-methylidene-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate
methyl (2s)-3-[(1z,12z)-13-bromo-13-chlorotrideca-1,12-dien-1-yl]-2h-azirine-2-carboxylate
(1s,13r,15r,16s,18r,19r)-9,15-dimethoxy-5,7,17-trioxa-12-azahexacyclo[10.6.2.0¹,¹³.0²,¹⁰.0⁴,⁸.0¹⁶,¹⁸]icosa-2,4(8),9-trien-19-yl acetate
1-[(11r)-12-methyl-5,7,17,19-tetraoxa-12-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tetracosa-1(13),2,4(8),9,14,16(20),21,23-octaen-11-yl]propan-2-one
C23H19NO5 (389.12631640000006)
methyl 3-(13-bromo-13-chlorotrideca-1,12-dien-1-yl)-2h-azirine-2-carboxylate
(2s,7r)-10-acetyl-4-ethanimidoyl-7-ethoxy-3,11,13-trihydroxy-2,12-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-5-one
(7r)-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-6-hydroxy-7-methyl-8-oxoisoquinolin-7-yl acetate
C21H24ClNO4 (389.13937740000006)
1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-hydroxy-3-methylbutan-2-yl acetate
6-acetonylsanguinarine
C23H19NO5 (389.12631640000006)
{"Ingredient_id": "HBIN012155","Ingredient_name": "6-acetonylsanguinarine","Alias": "NA","Ingredient_formula": "C23H19NO5","Ingredient_Smile": "NA","Ingredient_weight": "389.407","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7588","PubChem_id": "NA","DrugBank_id": "NA"}
1-{12-methyl-5,7,17,19-tetraoxa-12-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tetracosa-1(13),2,4(8),9,14,16(20),21,23-octaen-11-yl}propan-2-one
C23H19NO5 (389.12631640000006)
1-[(11s)-12-methyl-5,7,17,19-tetraoxa-12-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tetracosa-1(13),2,4(8),9,14,16(20),21,23-octaen-11-yl]propan-2-one
C23H19NO5 (389.12631640000006)
(1r,2r)-1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-hydroxy-3-methylbutyl acetate
(1s,4z,6r,7s)-4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate
(1s,6r,7s)-4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate
(1s,4e,6r,7r)-4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate
(2r)-1-({4,7-dimethoxyfuro[2,3-b]quinolin-6-yl}oxy)-3-hydroxy-3-methylbutan-2-yl acetate
(2r,3r,4s,5r)-2-(6-hydroxy-2-imino-3h-purin-9-yl)-5-(hydroxymethyl)-2-[(4-hydroxyphenyl)methyl]oxolane-3,4-diol
2-{[(5-amino-5-carboxy-1-hydroxypentylidene)amino](carboxy)methyl}-5-formyl-3,6-dihydro-2h-1,3-thiazine-4-carboxylic acid
(1s,4z,6s,7s)-4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate
7,17,18-trimethoxy-21-methyl-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1,3,5,7,9,11,15,17,19-nonaen-14-one
C22H19N3O4 (389.13754940000007)
2-{1-acetyl-5-hydroxy-3-methyl-4,9-dioxobenzo[f]isoindol-2-yl}benzoic acid
C22H15NO6 (389.08993300000003)
5-chloro-3-(3,5-dimethylhepta-1,3-dien-1-yl)-7-methyl-6,8-dioxo-2h-isoquinolin-7-yl acetate
C21H24ClNO4 (389.13937740000006)
4-ethylidene-6,7-dimethyl-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate
(2s)-2-carboxy-1-{2-[(2s)-2,6-dicarboxy-2,3-dihydro-1h-pyridin-4-ylidene]ethylidene}-5,6-dihydroxy-2,3-dihydro-1h-1λ⁵-indol-1-ylium
12-acetyl-4-ethanimidoyl-7-ethoxy-3,11,13-trihydroxy-2,10-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-5-one
(4s,5r,6r)-6-[(1r,2r)-1,2-dihydroxy-3-(phosphonooxy)propyl]-2,4-dihydroxy-5-[(1-hydroxyethylidene)amino]oxane-2-carboxylic acid
C11H20NO12P (389.0723090000001)
(2s,7r)-12-acetyl-4-ethanimidoyl-7-ethoxy-3,11,13-trihydroxy-2,10-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-5-one
(1r,11s,13s,14r,15s,16s)-16-hydroxy-14,15-dimethoxy-20-methyl-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-19-one
(2r)-2-hydroxy-n-[(1s)-1-[(3r)-8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl]-3-methylbutyl]-2-[(2s)-5-oxo-2h-furan-2-yl]ethanimidic acid
(7r)-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-7-methyl-6,8-dioxo-2h-isoquinolin-7-yl acetate
C21H24ClNO4 (389.13937740000006)
1-[(23r)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaen-23-yl]propan-2-one
C23H19NO5 (389.12631640000006)
10-acetyl-4-ethanimidoyl-7-ethoxy-3,11,13-trihydroxy-2,12-dimethyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),3,9,11-tetraen-5-one
(1s,5s,6s,7r)-5,6,7-trimethyl-4-methylidene-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate
1-[(23s)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaen-23-yl]propan-2-one
C23H19NO5 (389.12631640000006)
(2s)-2-hydroxy-n-[(1s)-1-[(3s)-8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl]-3-methylbutyl]-2-[(2s)-5-oxo-2h-furan-2-yl]ethanimidic acid
(1r,5s,6r,7r)-5,6,7-trimethyl-4-methylidene-3,8,15-trioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadeca-11(17),12-dien-7-yl acetate
1-methyl-18-oxa-7,10,11-triazahexacyclo[15.6.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-2,4(13),6,14,17(24),19-hexaene-5,12,16,21-tetrone
C21H15N3O5 (389.10116600000003)